Concurrent Investment Advisors, LLC Vertex Pharmaceuticals Inc Transaction History
Concurrent Investment Advisors, LLC
- $4.12 Trillion
- Q1 2025
A detailed history of Concurrent Investment Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Concurrent Investment Advisors, LLC holds 3,213 shares of VRTX stock, worth $1.42 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
3,213
Previous 2,072
55.07%
Holding current value
$1.42 Million
Previous $834 Million
86.69%
% of portfolio
0.04%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding VRTX
# of Institutions
1,832Shares Held
233MCall Options Held
1.38MPut Options Held
1.08M-
Capital World Investors Los Angeles, CA28.5MShares$12.6 Billion2.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.5MShares$10.4 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.42 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.5MShares$6.43 Billion1.6% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.21 Billion0.24% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $113B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...